MENS
Jyong Biotech
MENS
MENS
17 hedge funds and large institutions have $974K invested in Jyong Biotech in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
64% less capital invested
Capital invested by funds: $2.73M → $974K (-$1.76M)
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$34.1K | |
| 2 | +$28.8K | |
| 3 | +$16.9K | |
| 4 |
Barclays
London,
United Kingdom
|
+$4.03K |
| 5 |
CUAMC
China Universal Asset Management Company
Shanghai,
China
|
+$1.92K |
Top Sellers
| 1 | -$275K | |
| 2 | -$265K | |
| 3 | -$91.6K | |
| 4 |
Millennium Management
New York
|
-$62.8K |
| 5 |
Man Group
London,
United Kingdom
|
-$56.2K |